The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CLOVER HEALTH INVESTMENTS CO | COM CL A | 18914F103 | 3,356 | 1,973,944 | SH | SOLE | 1,973,944 | 0 | 0 | ||
| DOMA HOLDINGS INC | COMMON STOCK | 25703A104 | 936 | 2,129,485 | SH | SOLE | 2,129,485 | 0 | 0 | ||
| LEMONADE INC | COM | 52567D107 | 8,107 | 382,777 | SH | SOLE | 382,777 | 0 | 0 | ||
| KAIROS ACQUISITION CORP | *W EXP 11/30/202 | G52110106 | 194 | 6,283,265 | SH | SOLE | 6,283,265 | 0 | 0 | ||
| KAIROS ACQUISITION CORP | CL A SHS | G52110114 | 19,701 | 1,980,000 | SH | SOLE | 1,980,000 | 0 | 0 | ||